Page last updated: 2024-08-21

nandrolone and HIV Coinfection

nandrolone has been researched along with HIV Coinfection in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (42.86)18.2507
2000's4 (57.14)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Azen, S; Blanche, PJ; Dube, MP; Jaque, SV; Krauss, RM; Martinez, C; Sattler, FR; Schroeder, ET1
Bretón, I; Camblor, M; Cuerda, C; García, P; Miralles, P; Zugasti, A1
Brewer, RB; Carson, JA; Dudgeon, WD; Durstine, JL; Hand, GA; Phillips, KD1
Allen, BJ; Bodsworth, NJ; Finlayson, R; Furner, VL; Gold, J; High, HA; Li, Y; Michelmore, H; Oliver, CJ1
Gorbacheva, ES; Gruzdev, BM; Ivannikov, EV1

Reviews

1 review(s) available for nandrolone and HIV Coinfection

ArticleYear
Counteracting muscle wasting in HIV-infected individuals.
    HIV medicine, 2006, Volume: 7, Issue:5

    Topics: Cytokines; Exercise Therapy; Growth Hormone; HIV Infections; HIV Wasting Syndrome; Hormone Replacement Therapy; Humans; Insulin-Like Growth Factor I; Malnutrition; Muscular Atrophy; Nandrolone; Nandrolone Decanoate; Testosterone

2006

Trials

3 trial(s) available for nandrolone and HIV Coinfection

ArticleYear
Metabolic effects of nandrolone decanoate and resistance training in men with HIV.
    American journal of physiology. Endocrinology and metabolism, 2002, Volume: 283, Issue:6

    Topics: Adult; Androgens; Blood Glucose; Body Composition; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Energy Intake; Energy Metabolism; Exercise; HIV Infections; Humans; Insulin; Insulin Resistance; Lipoprotein(a); Lipoproteins, LDL; Male; Nandrolone; Nandrolone Decanoate; Particle Size; Triglycerides

2002
Safety and efficacy of nandrolone decanoate for treatment of wasting in patients with HIV infection.
    AIDS (London, England), 1996, Volume: 10, Issue:7

    Topics: Acquired Immunodeficiency Syndrome; Adult; Anthropometry; Body Mass Index; Body Weight; CD4 Lymphocyte Count; Dietary Fats; HIV Infections; HIV Wasting Syndrome; Humans; Male; Middle Aged; Nandrolone; Nandrolone Decanoate; Nitrogen; Quality of Life; Surveys and Questionnaires

1996
Anabolic steroid boosts weight.
    GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 1996, Volume: 10, Issue:9

    Topics: Cachexia; HIV Infections; Humans; Menstruation Disturbances; Nandrolone; Placebos; Sarcoma, Kaposi; Testosterone; Weight Gain

1996

Other Studies

3 other study(ies) available for nandrolone and HIV Coinfection

ArticleYear
Nandrolone: generic now in stock.
    AIDS treatment news, 2002, Aug-09, Issue:382

    Topics: Drugs, Generic; HIV Infections; Humans; Internet; Nandrolone

2002
Treatment with nandrolone decanoate and megestrol acetate in HIV-infected men.
    Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition, 2005, Volume: 20, Issue:1

    Topics: Adult; Anabolic Agents; Anthropometry; Appetite Stimulants; Drug Therapy, Combination; HIV Infections; HIV Wasting Syndrome; Humans; Male; Megestrol Acetate; Muscle, Skeletal; Nandrolone; Nandrolone Decanoate; Quality of Life; Safety; Testosterone; Treatment Outcome; Weight Gain

2005
[Anabolic therapy in patients with HIV infections].
    Terapevticheskii arkhiv, 1999, Volume: 71, Issue:11

    Topics: Adult; Anabolic Agents; Appetite; Body Mass Index; Diarrhea; Female; HIV; HIV Infections; Humans; Injections, Intramuscular; Male; Nandrolone; Quality of Life; Treatment Outcome; Weight Loss

1999